Amy Parker
Family · Haddon Township, NJNPI 1275961948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Atricure, Inc. at 29.7% of the total.
Across 17 payments — averaging $27.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$140
- Boston Scientific$95
- Bard Peripheral Vascular, Inc.$79
- Novo Nordisk$77
- Abbott$33
- Inspire Medical Systems, Inc.$28
- plus $18 from 1 others
What the payments were for
- Food & beverage$470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 3 | $140 |
| Boston Scientific | 4 | $95 |
| Bard Peripheral Vascular, Inc. | 3 | $79 |
| Novo Nordisk | 4 | $77 |
| Abbott | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Cashflow Solutions, LLC | 1 | $18 |
How this compares
$470 in reported general payments places this provider in the 60th percentile of 2,692 family providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 34 | $51,634 |
| Repatha SureclickEvolocumab | 11 | $17,999 |
| Cilostazol | 27 | $983 |
| Rosuvastatin Calcium | 32 | $879 |
| Ezetimibe | 15 | $349 |
| Gabapentin | 19 | $316 |
| ClopidogrelClopidogrel Bisulfate | 31 | $276 |
| Atorvastatin Calcium | 17 | $178 |
| Amlodipine Besylate | 11 | $156 |
| Doxycycline Hyclate | 13 | $91 |
| Furosemide | 13 | $39 |
| Prednisone | 19 | $19 |
Paid to pharmacies, not to this prescriber.
Other family in Haddon Township
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
- Toni Michelle SeibertColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.